Printed material distributed by pharmaceutical propaganda agents

Medicina

Volumn 61, Issue 3, 2001, Pages 315-318

  Mejia R ^a   Avalos, A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Advertising; Drug promotion; Pharmaceutical companies

Indexed keywords

DRUG;

ACCURACY; ADVERSE DRUG REACTION; ARGENTINA; ARTICLE; BOOK; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG INFORMATION; DRUG INTERACTION; DRUG MARKETING; DRUG RESEARCH; ELECTRONICS; ERROR; EVALUATION; INFORMATION PROCESSING; INTERNAL MEDICINE; LIBRARY; MEDICAL INFORMATION; PHARMACOLOGY; PHYSICIAN; RANDOMIZATION; SAMPLE; ADVERTIZING; DRUG INDUSTRY; DRUG LABELING; HUMAN; STANDARD;

ADVERTISING; DRUG INDUSTRY; DRUG INFORMATION SERVICES; DRUG LABELING; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 0035232625     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. The nonpharmacologic basis of therapeutics
2. Scientific versus commercial sources of influence on the prescribing behavior of physicians
3. Rational prescribing and sources of information
4. Review of literature on the factors affecting drug prescribing
5. Why do American drugs companies spend more than $12 billion a year pushing drugs? Is it education or promotion?
6. The role of commercial sources in the adoption of a new drug
7. Physicians and the farmaceutical industry. Is a gift ever just a gift?
8. A physician survey of the effect of drug sample availability on physician's behavior
9. Physician's behavior and their interaction with drug companies
10. A comparison of phisician's and patient's attitudes toward pharmaceutical industry gifts
11. Pharmaceutical marketing has real and proven value
12. Pharmaceutical representatives in academic medical centers: Interaction with faculty and housestaff
13. Attitudes of general practitioners in New Zealand to pharmaceutical representatives
14. The FDA and drug marketing expenditures
15. The evolving role of FDA in prescription drug promotion
16. Pro-free enterprise group challenges FDA's authority to regulate drug companies speech
17. Characteristics of materials distributed by drug companies
18. Why would anyone have expected anything else?
19. The accuracy of drug information from pharmaceutical sales representatives
20. What information do physicians receive from pharmaceutical representatives
21. Separating the wheat from the chaff: Identifying fallacies in pharmaceutical promotion
22. Goodman & Gilman's. The pharmacological Basis of Medical Therapeutics
23. Uniform requirements for manuscripts submitted to biomedical journals
24. User's guides to the medical literature. I. How to get started
25. Pharmacists' and physicians' attitudes toward pharmaceutical marketing practices
26. Drug companies and information about drugs: Recommendations for doctors
27. Why no free lunch?
28. Reasons for not seeing drug representatives